Search - tctmd.com

Displaying 41 - 60 of 238

Sort: Relevancy | Date

News Daily News

FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients

L.A. McKeown

August 21, 2024

News Daily News

FDA Medical Devices Chief Jeff Shuren Announces Retirement

L.A. McKeown

July 24, 2024

News Daily News

Device Correction Issued for HeartMate Monitor Due to Potential Pump Stoppage

Todd Neale

June 28, 2024

Presentation NY Valves 2024

Transfemoral TAVI With Dedicated Device for Severe Aortic Regurgitation in Patient With Left Ventricular Assist Device With Aortic Cusp Thrombus

Presenter: Simon Lam

June 06, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2024

Shelley Wood

May 31, 2024

News Daily News

HeartMate 3 Recalled for Risk of Blood Leaks or Air in System

L.A. McKeown

May 15, 2024

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

News Daily News

HeartMate II and 3 LVADs Recalled Due to Potential for Outflow Graft Obstruction

Caitlin E. Cox

April 22, 2024

News Daily News

In Transporting Donor Hearts, SherpaPak Shows Promise Over Traditional Coolers

Yael L. Maxwell

April 18, 2024

News Conference News ACC 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Michael O'Riordan

April 06, 2024

News Conference News CRT 2024

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

L.A. McKeown

March 15, 2024

News Daily News

Cognitive Impairment a Real Concern in HF Patients: HFSA

Caitlin E. Cox

March 13, 2024

Podcast TCTMD Talking Points

The ARIE-HM3 Trial

March 13, 2024

News Conference News CRT 2024

Open SESAME? Transcatheter Myotomy Shows Promise for LVOT Obstruction

L.A. McKeown

March 12, 2024

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

Presentation THT Abstracts 2024

Durable Left Ventricular Assist Devices Improve Microcirculatory Health

Presenter: Boaz Elad

March 05, 2024

Presentation THT Abstracts 2024

Glucagon-Like Peptide-1 Agonist Experience in Patients With Left Ventricular Assist Devices

Presenter: Boaz Elad

March 05, 2024

Presentation THT Abstracts 2024

Center variability in patient management may influence incidence of infection during durable left ventricular assist device support 2013 an analysis from the ASPIRE Survey and STS Intermacs

Presenter: Jennifer Cowger

March 05, 2024

Presentation THT Abstracts 2024

Functional Outcomes Following Temporary Mechanical Circulatory Support Bridging to Left Ventricular Assist Device (LVAD)

Presenter: John Eisenga

March 05, 2024

Advertisement

FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients

FDA Medical Devices Chief Jeff Shuren Announces Retirement

Device Correction Issued for HeartMate Monitor Due to Potential Pump Stoppage

Transfemoral TAVI With Dedicated Device for Severe Aortic Regurgitation in Patient With Left Ventricular Assist Device With Aortic Cusp Thrombus

TCTMD’s Top 10 Most Popular Stories for May 2024

HeartMate 3 Recalled for Risk of Blood Leaks or Air in System

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

HeartMate II and 3 LVADs Recalled Due to Potential for Outflow Graft Obstruction

In Transporting Donor Hearts, SherpaPak Shows Promise Over Traditional Coolers

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

Cognitive Impairment a Real Concern in HF Patients: HFSA

The ARIE-HM3 Trial

Open SESAME? Transcatheter Myotomy Shows Promise for LVOT Obstruction

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Durable Left Ventricular Assist Devices Improve Microcirculatory Health

Glucagon-Like Peptide-1 Agonist Experience in Patients With Left Ventricular Assist Devices

Center variability in patient management may influence incidence of infection during durable left ventricular assist device support 2013 an analysis from the ASPIRE Survey and STS Intermacs

Functional Outcomes Following Temporary Mechanical Circulatory Support Bridging to Left Ventricular Assist Device (LVAD)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content